Alexey Tryakin - Dissemin

Language
Login

All papers authored by Alexey Tryakin

This paper is made freely available by the publisher.

2024 Alexandra Lebedeva

ORCID

, Olesya Kuznetsova, Maxim Ivanov

ORCID

, Alexandra Kavun

ORCID

, Egor Veselovsky

ORCID

, Ekaterina Belova

ORCID

, Vladislav Mileyko, Valentina Yakushina

ORCID

, Polina Shilo, Alexey Tryakin

ORCID

, Alexey Rumyantsev, Fedor Moiseenko

ORCID

, Mikhail Fedyanin

ORCID

, Dmitry Nosov

Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experience

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Mikhail Fedyanin

ORCID

, Alexey A. Rumyantsev

ORCID

, Alexey A. Tryakin

ORCID

Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment. A review

Upload

This paper is made freely available by the publisher.

Priya Rastogi

ORCID

, Joyce O'Shaughnessy, Miguel Martin

ORCID

, Frances Boyle

ORCID

, Javier Cortes

ORCID

ORCID

, Matthew P. Goetz

ORCID

, Erika P. Hamilton

ORCID

, Chiun-Sheng Huang

ORCID

, Elzbieta Senkus, Alexey Tryakin

ORCID

ORCID

ORCID

, Patrick Neven

ORCID

ORCID

and 8 other authors

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

Download from doi.org

This paper is made freely available by the publisher.

2023 Alexey A. Rumyantsev

ORCID

, Alexandra S. Tyulyandina

ORCID

, Alexey A. Tryakin

ORCID

, Mikhail Y. Fedyanin

ORCID

, Sergey A. Tjulandin

ORCID

Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative

Download from doi.org

This paper is made freely available by the publisher.

Elizaveta Polyanskaya, Alexandra Lebedeva, Olesya Kuznetsova, Ekaterina Belova, Alexandra Kavun

ORCID

, Maxim Ivanov, Mikhail Fedyanin, Alexey Tryakin

ORCID

, Vladislav Mileyko, Dmitry Nosov

Case Report: Progressive disease of BRCA2-mutant colon adenocarcinoma following talazoparib therapy

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Xavier Garcia del Muro

ORCID

, Jakob Lauritsen

ORCID

, Nicolas Sauvé, Alexey Tryakin

ORCID

, Di Maria Jiang

ORCID

, Robert A. Huddart

ORCID

, Daniel Y. C. Heng, Angelika Terbuch, Eric Winquist, Michal Chovanec

ORCID

, Marcus Hentrich, Silke Gillessen, Christian D. Fankhauser

ORCID

, Jonathan Shamash, Cora N. Sternberg and 11 other authors

Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database

Upload

This paper is made freely available by the publisher.

H. Sun

ORCID

ORCID

, A. A. Tryakin

ORCID

, E. V. Artamonova

ORCID

, A. E. Kalinin

ORCID

ORCID

, A. M. Stroganova, N. S. Besova

ORCID

, P. P. Arkhiri

ORCID

, V. I. Marshall

ORCID

, R. S.-H. Abdulaeva

ORCID

, I. S. Stilidi

ORCID

The results of treatment for resectable gastric cancer with microsatellite instability

Download from doi.org

This paper is made freely available by the publisher.

Olesya Kuznetsova, Maxim Ivanov, Alexey Tryakin

ORCID

, Alexandra Lebedeva, Ekaterina Ignatova, Mikhail Fedyanin

Comprehensive multigene profiling impact on clinical decisions in patients with advanced cancers: A multicenter, retrospective analysis.

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Luca Antonelli, Davide Ardizzone, Praful Ravi, Aditya Bagrodia, Michal Mego, Siamak Daneshmand, Nicola Nicolai, Sebastiano Nazzani, Patrizia Giannatempo, Andrea Franza, Axel Heidenreich, Pia Paffenholz, Ragheed Saoud, Scott Eggener, Matthew Ho and 13 other authors

Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study

Upload

This paper is made freely available by the publisher.

Alexandra Lebedeva, Grigory Timokhin, Ekaterina Ignatova, Alexandra Kavun

ORCID

, Egor Veselovsky

ORCID

, Margarita Sharova, Vladislav Mileyko, Valentina Yakushina, Olesya Kuznetsova, Maria Stepanova, Polina Shilo, Fedor Moiseenko, Nikita Volkov, Igor Plaksa, Andrey Isaev and 11 other authors

Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results

Download from link.springer.com

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Y. Chikhareva, M. Fedyanin, I. Bazin, I. Pokataev, M. Manukyan, D. Kantieva, A. Tryakin

ORCID

Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

A. Tryakin

ORCID

, M. Fedyanin, M. Mariam, F. Moiseenko, O. Mironov, D. Stroyakovskiy, R. Orlova, N. Sokolov, S. Orlova, E. Mantsyrev, A. Sultanbaev, A. Teterich, K. Babina, D. Iukalchuk, S. Borzyanitsa and 5 other authors

Final results of APOLLON-11 and SOYUZ-APOLLON study: Multicentre prospective observational post-authorization study of bevacizumab biosimilar in patients with metastatic colorectal cancer in real-world practice

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

H. Sun, S. Nered, A. Tryakin

ORCID

, Bugaev, I. Peregorodiev, I. Stilidi

The role of preoperative immune-chemotherapy in locally advanced resectable gastric cancer with microsatellite instability

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

M. Manukyan, I. Bazin, Y. Chikhareva, A. Tryakin

ORCID

Efficacy of the combined chemotherapy regimens in elderly patients with advanced pancreatic cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

D. Kantieva, I. Bazin, D. Podluzhnyi, M. Manukyan, Y. Chikhareva, A. Polyakov, N. Kudashkin, A. Kotelnikov, A. Petrosyan, I. Pogrebnyakov, E. Moroz, A. Tryakin

ORCID

Neoadjuvant chemotherapy of the mFOLFIRINOX in the treatment of resectable pancreatic cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

N. Harbeck, P. Rastogi, J. O'Shaughnessy, F. Boyle, J. Cortes, H. S. Rugo, M. P. Goetz, E. P. Hamilton, C. Huang, E. Senkus-Konefka, A. Tryakin

ORCID

, P. Neven, J. Huober, R. J. Wei, Andre and 5 other authors

Adjuvant abemaciclib plus endocrine therapy for HR+, HER2-, high-risk early breast cancer: Results from a preplanned monarchE overall survival interim analysis, including 5-year efficacy outcomes

Upload

This paper is made freely available by the publisher.

2022 Luca Antonelli, Davide Ardizzone, Praful Ravi, Christopher Sweeney, Aditya Bagrodia, Michal Mego, Sia Daneshmand, T. Campanelli Palmer, Sebastiano Nazzani, Patrizia Giannatempo, Andrea Franza, Axel Heidenreich, Pia Paffenholz, Ragheed Saoud, Antoin Douglawi and 12 other authors

Risk of residual teratoma after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumor and IGCCCG intermediate/poor prognosis: A multi-institutional retrospective cohort study

Download from doi.org

This paper is made freely available by the publisher.

M. S.-H. Manukyan, I. S. Bazin, A. A. Tryakin

ORCID

Chemotherapy for advanced pancreatic cancer in older patients (literature review)

Download from ok.abvpress.ru

This paper is made freely available by the publisher.

Alexandra Lebedeva, Maxim Ivanov, Ekaterina Ignatova, Grigoriy Timokhin, Margarita Sharova, Vladislav Mileyko, Valentina Yakushina, Kuznetsova Olesya, Maria Stepanova, Polina Shilo, Fedor Vladimirovich Moiseenko, Nikita Volkov, Igor Plaksa, Andrey Isaev, Margarita Gayryan and 5 other authors

Utility of public Knowledge Bases (KB) for comprehensive tumor molecular profiling (CTMP) result interpretation.

Download from doi.org

Missing publications? Search for publications with a matching author name.